Company / Return on Assets (ROA)
ORAMED PHARMACEUTICALS INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-8.3%
FY2025
5-year range
-16.6% / 3.3%
FY2021-FY2025
Trend
-351.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -352% YoY in FY2025, a notable deviation from the 9-year average annual change of -37%.
Based on SEC 10-K filings.
-8.3% in FY2025 with a 5-year CAGR of +23.9%.
Improved from -16.6% to -8.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +6.0pp
- 5-Year Change
- +23.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 351.8% year-over-year.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8.3% | -351.8% |
| FY2024 | 3.3% | +119.8% |
| FY2023 | -16.6% | -16.6% |
| FY2022 | -14.2% | -58.2% |
| FY2021 | -9.0% | +72.0% |
| FY2020 | -32.2% | -6.4% |
| FY2019 | -30.2% | -30.7% |
| FY2018 | -23.1% | -23.8% |
| FY2017 | -18.7% | -40.5% |
| FY2016 | -13.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026